October 2023 ACIP Meeting - Public comment & RSV Vaccines

preview_player
Показать описание
Public comment; VOTES; RSV-Adults: Introduction; GSK safety and immunogenicity in persons 50-59 years of age;Epidemiology of RSV in adults;Work group interpretation and ACIP discussion

This video can also be viewed at
Рекомендации по теме